March 10, 2022
Video
Ursula A. Matulonis, MD, discusses the impact of PARP inhibitors on ovarian cancer treatment.
March 24, 2016
Video
Ursula Matulonis, MD, medical director of Gynecologic Oncology at Dana-Farber Cancer Institute, discusses two upcoming trials for both platinum-resistant and platinum-sensitive recurrent ovarian cancer.